VivoSeq
Other

Hypoventilation

4

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Hypoventilation is an early-stage landscape with 4 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

6/100

Mech. Concentration

100/100

Completion Rate

40/100

Attrition Rate

43/100

Pipeline

Programs by Phase

Analysis

Trial Status

7

clinical trials

Completed2 · 29%
Withdrawn2 · 29%
Not yet recruiting1 · 14%
Unknown status1 · 14%
Terminated1 · 14%

Clinical Trials

Trial Activity

7 trials

Identifying Biomarkers & Dysregulated Biological Pathways in Blood and Urine of Congenital Central Hypoventilation Syndrome (CCHS) Patients
Not yet recruiting·AAssistance Publique - Hôpitaux de Paris·N/A·NCT06997146·40 enrolled
Study of AD981 Versus Placebo in Obesity Hypoventilation Syndrome
Completed·—·Phase 2·NCT05448443·15 enrolled
Ketamine Infusion and Hypoventilation
Completed·NNorthwestern University·N/A·NCT01535976·54 enrolled
Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome
Terminated·—·Phase 2·NCT01500473·1 enrolled
Treatment of Rapid Onset Obesity, Hypoventilation, Hypothalamic Dysfunction, and Autonomic Dysregulation (ROHHAD )
Withdrawn·JJohns Hopkins University·N/A·NCT02441491
The Effect of Ketamine in the Prevention of Hypoventilation in Patients Undergoing Deep Sedation Using Propofol and Fentanyl
Withdrawn·NNorthwestern University·N/A·NCT01825083
Opioid-sparing Versus Sevoflurane Anesthesia on Early Postoperative Hypoventilation in Laparoscopic Bariatric Surgery
Unknown status·TTanta University·Phase 4·NCT05962671·72 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)